全文获取类型
收费全文 | 158068篇 |
免费 | 31885篇 |
国内免费 | 2402篇 |
专业分类
耳鼻咽喉 | 5230篇 |
儿科学 | 5658篇 |
妇产科学 | 2583篇 |
基础医学 | 4097篇 |
口腔科学 | 1570篇 |
临床医学 | 27704篇 |
内科学 | 48628篇 |
皮肤病学 | 7537篇 |
神经病学 | 15416篇 |
特种医学 | 6519篇 |
外科学 | 41725篇 |
综合类 | 369篇 |
现状与发展 | 72篇 |
一般理论 | 6篇 |
预防医学 | 8233篇 |
眼科学 | 3523篇 |
药学 | 1279篇 |
中国医学 | 10篇 |
肿瘤学 | 12196篇 |
出版年
2024年 | 697篇 |
2023年 | 4878篇 |
2022年 | 1341篇 |
2021年 | 3443篇 |
2020年 | 6199篇 |
2019年 | 2475篇 |
2018年 | 7679篇 |
2017年 | 7543篇 |
2016年 | 8630篇 |
2015年 | 8616篇 |
2014年 | 15779篇 |
2013年 | 16009篇 |
2012年 | 6082篇 |
2011年 | 6048篇 |
2010年 | 10594篇 |
2009年 | 14469篇 |
2008年 | 6158篇 |
2007年 | 4390篇 |
2006年 | 6797篇 |
2005年 | 4104篇 |
2004年 | 3324篇 |
2003年 | 2266篇 |
2002年 | 2262篇 |
2001年 | 3886篇 |
2000年 | 3075篇 |
1999年 | 3287篇 |
1998年 | 3700篇 |
1997年 | 3494篇 |
1996年 | 3394篇 |
1995年 | 3229篇 |
1994年 | 1974篇 |
1993年 | 1594篇 |
1992年 | 1425篇 |
1991年 | 1458篇 |
1990年 | 1121篇 |
1989年 | 1241篇 |
1988年 | 1060篇 |
1987年 | 898篇 |
1986年 | 927篇 |
1985年 | 749篇 |
1984年 | 569篇 |
1983年 | 552篇 |
1982年 | 527篇 |
1981年 | 409篇 |
1980年 | 370篇 |
1979年 | 330篇 |
1978年 | 350篇 |
1977年 | 426篇 |
1975年 | 293篇 |
1972年 | 323篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
71.
72.
73.
74.
75.
76.
77.
As the proportion of racial, ethnic, and cultural minorities in the United States continues to expand, pediatric emergency medicine providers are increasingly likely to encounter cultural and language barriers in practice. This paper reviews a conceptual framework encompassing the decision to seek emergency care, the process of providing such care, and the adherence to treatment plans and follow-up. The ways in which cultural and language barriers can negatively impact each element of this model are discussed in detail. Specific examples include provider ignorance of dangerous folk beliefs, communication barriers secondary to inappropriate interpreter use, and discriminatory assumptions regarding child abuse, pain management, and sexual activity. The practitioner is then provided with concrete recommendations to reduce these negative effects. 相似文献
78.
Eric T. Stoopler DMD res Pinto DMD Faizan Alawi DDS Sree Raghavendra DMD Ricardo Boyce Jr. DDS David Porter MD Thomas P. Sollecito DMD 《Special care in dentistry》2004,24(2):65-69
Acute myelogenous leukemia (AMU is a hematologic disorder that is characterized by an abnormal proliferation of immature myeloid cells. Granulocytic sarcomas are clusters of leukemic myeloid cells that may develop as a result of AML. Oral manifestations of AML are common and often involve enlargements of the gingiva and/or mucosal tissue from direct leukemia cell infiltration. We describe the case history of a 50-year-old man who had an ulcera-tive lesion of the oral mucosa that was determined to be a granulocytic sarcoma of AML-M0 subtype. The combination of both the subtype and clinical presentation of the leukemia makes this presentation unusual, and to the best of our knowledge, of a type that has not been previously reported in the literature. 相似文献
79.
80.
ROBERT A. WEISS MD MARGARET A. WEISS MD KAREN L. BEASLEY MD GIRISH MUNAVALLI MD 《Dermatologic surgery》2007,33(3):263-268
BACKGROUND: Previous data indicate that injections of autologous fibroblasts increase collagen formation, accompanied by a concomitant increase in thickness and density of dermal collagen. OBJECTIVE: The purpose of this study was to determine efficacy and side effects of autologous living fibroblast injections versus placebo in a randomized Phase III trial for the treatment of various facial contour defects. METHODS: This was a double-blind, randomized comparison of injectable living autologous fibroblast cells and placebo for the treatment of facial contour defects (N=215). Live fibroblasts (20 million/mL) or placebo (the transport medium without living cells) were given as three doses administered at 1- to 2-week intervals. Efficacy evaluations were performed 1, 2, 4, 6, 9, and 12 months after the first injection. RESULTS: Living fibroblasts produced statistically significantly greater improvements in dermal deformities and acne scars than did placebo. The difference between live fibroblast injections and placebo achieved statistical significance at 6 months (p<.0001). At 9- and 12-month follow-up, live fibroblast-treated patients continued to demonstrate benefit from treatment with response rates of 75.0 and 81.6%, respectively. No serious treatment-related adverse events were reported. CONCLUSIONS: Our results indicate that autologous fibroblast injections can safely and effectively produce improvements in rhytids, acne scars, and other dermal defects continuing for at least 12 months after injection. 相似文献